Literature DB >> 12948354

Transplantation of neural stem cells into the spinal cord after injury.

Hideyuki Okano1, Yuto Ogawa, Masaya Nakamura, Shinjiro Kaneko, Akio Iwanami, Yoshiaki Toyama.   

Abstract

Thanks to advances in the stem cell biology of the central nervous system (CNS), the previously inconceivable regeneration of the damaged CNS is approaching reality. The availability of signals to induce the appropriate differentiation of the transplanted and/or endogenous neural stem cells (NSCs) as well as the timing of the transplantation are important for successful functional recovery of the damaged CNS. Because the immediately post-traumatic microenvironment of the spinal cord is in an acute inflammatory stage, it is not favorable for the survival and differentiation of NSC transplants. On the other hand, in the chronic stage after injury, glial scars form in the injured site that inhibit the regeneration of neuronal axons. Thus, we believe that the optimal timing of transplantation is 1-2 weeks after injury.

Mesh:

Year:  2003        PMID: 12948354     DOI: 10.1016/s1084-9521(03)00011-9

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  41 in total

Review 1.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

Review 2.  Neural stem cells: involvement in adult neurogenesis and CNS repair.

Authors:  Hideyuki Okano; Kazunobu Sawamoto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

3.  Contribution of subcutaneous connective tissues to the epithelialization and cyst formation by the skin transplanted subcutaneously.

Authors:  Hajime Sawada; Hong-Ming Sheng; Yoji Hakamata; Michiyo Esaki; Asami Kita; Toyokazu Yoshida; Eiji Kobayashi
Journal:  Organogenesis       Date:  2004-10       Impact factor: 2.500

4.  Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases.

Authors:  Mari Dezawa; Hiroto Ishikawa; Mikio Hoshino; Yutaka Itokazu; Yo-ichi Nabeshima
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

5.  Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury.

Authors:  Angelo C Lepore; John O'Donnell; Andrew S Kim; Eun Ju Yang; Alisha Tuteja; Amanda Haidet-Phillips; Colin P O'Banion; Nicholas J Maragakis
Journal:  Glia       Date:  2011-08-31       Impact factor: 7.452

Review 6.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

7.  Recovery of CNS pathway innervating the sciatic nerve following transplantation of human neural stem cells in rat spinal cord injury.

Authors:  Kwang-Bok Lee; Jung Hoon Choi; Kyunghee Byun; Kwang Hoon Chung; Ji Hyeon Ahn; Goo-Bo Jeong; In Koo Hwang; Seungup Kim; Moo-Ho Won; Bonghee Lee
Journal:  Cell Mol Neurobiol       Date:  2011-08-11       Impact factor: 5.046

8.  In vivo intermolecular zero-quantum coherence MR spectroscopy in the rat spinal cord at 17.6 T: a feasibility study.

Authors:  David Z Balla; Cornelius Faber
Journal:  MAGMA       Date:  2007-09-18       Impact factor: 2.310

Review 9.  Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells.

Authors:  Masaya Nakamura; Hideyuki Okano
Journal:  Cell Res       Date:  2012-12-11       Impact factor: 25.617

10.  Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study.

Authors:  H S Chhabra; K Sarda; M Arora; R Sharawat; V Singh; A Nanda; G M Sangodimath; V Tandon
Journal:  Spinal Cord       Date:  2015-08-18       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.